Aug 24, 2026 05:16AM
Aug 14, 2026 07:14AM
Jul 29, 2026 09:26AM
Jul 29, 2026 09:25AM
May 11, 2026 04:50AM
May 11, 2026 04:30AM
Mar 24, 2026 09:33AM Alvotech SA (ALVO) PT Lowered to $6 at UBS, Stock Expected to Rerate as Visibility Improves
Dec 19, 2025 05:13AM
Dec 19, 2025 03:30AM
Dec 19, 2025 03:30AM
Dec 17, 2025 08:39AM
Nov 6, 2025 09:00AM
Nov 6, 2025 09:00AM
Nov 4, 2025 04:49AM Deutsche Bank Downgrades Alvotech SA (ALVO) to Hold
Nov 3, 2025 03:52AM
Nov 2, 2025 05:12PM
Nov 2, 2025 05:10PM
Oct 6, 2025 08:00AM
Sep 22, 2025 05:11AM
Sep 22, 2025 04:30AM
Sep 19, 2025 07:46AM Alvotech receives Japan approval for three biosimilars
Sep 19, 2025 07:45AM
Aug 21, 2025 04:30AM
Jul 9, 2025 04:30AM
Jul 9, 2025 04:30AM
Jun 23, 2025 05:14AM
Jun 23, 2025 04:00AM
Jun 23, 2025 04:00AM European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)
May 28, 2025 06:15AM
May 7, 2025 04:45PM
May 5, 2025 07:03AM
May 5, 2025 07:00AM
Mar 26, 2025 06:34PM
Mar 18, 2025 08:32AM
Mar 18, 2025 08:30AM Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
Feb 21, 2025 06:26AM
Feb 21, 2025 06:00AM
Feb 18, 2025 06:00AM
Feb 18, 2025 06:00AM
Jan 27, 2025 06:02AM
Jan 27, 2025 06:00AM
Jan 27, 2025 06:00AM Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)
Nov 13, 2024 04:05PM
Oct 22, 2024 07:07AM
Oct 22, 2024 07:00AM
May 20, 2024 08:25PM
May 20, 2024 08:25PM
Apr 30, 2024 04:00AM
Apr 19, 2024 06:10AM Alvotech (ALVO) signs U.S. agreement to expand access for adalimumab
Apr 19, 2024 06:10AM

330,120 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All